Andrine R. Swensen

Statistics

Publications

Citations

3.1K

H-Index

Active since

1997

Affiliations

Eli Lilly (United States)(Current)

University of Minnesota

Analysis Group (United States)

Masonic Cancer Center

The Barbara Ann Karmanos Cancer Institute

Andrine R. Swensen is an author at Eli Lilly (United States) specializing in medicine, attention-deficit/hyperactivity disorder, and neurodevelopmental disorders.

Publications per year

1997–2013

Publications

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD

David M. Mannino, Deborah B. Thorn, Andrine R. Swensen et al. · European Respiratory Journal · 2008 · 1.2K citations · Full text

Medicine, Health Sciences, Clinical Epidemiology +16

Treatment of COPD: Relationships between daily dosing frequency, adherence, resource use, and costs

Edmond L. Toy, Nicolas U. Beaulieu, Joshua McHale et al. · Respiratory Medicine · 2010 · 282 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +11

Comorbidities and Costs of Adult Patients Diagnosed with Attention-Deficit Hyperactivity Disorder

Kristina Secnik, Andrine R. Swensen, Maureen J. Lage · PharmacoEconomics · 2005 · 246 citations

Medicine, Pharmacoeconomics, Psychiatry +13

Costs of attention deficit–hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000

Howard G. Birnbaum, Ronald C. Kessler, Sarah W. Lowe et al. · Current Medical Research and Opinion · 2005 · 237 citations

Pharmacy, Pharmacoeconomics, Psychiatry +17

Attention-Deficit/Hyperactivity Disorder: Increased Costs for Patients and Their Families

Andrine R. Swensen, Howard G. Birnbaum, Kristina Secnik et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2003 · 188 citations

Medicine, Pediatrics, Psychiatry +14

1–5 of 18